International Stem Cell Corp. (ISCO)

[236T568]

are you forgetting that ISCO is controlled and run by sleazy Russian promoters?

That is about what I hoped for. Indications of efficacy at minimal dose levels. All patients so far, 'feel better'. That fact alone makes any monies lost here to date worthwhile. Why this company is still at such low valuation surprises me. I recognize the cash situation, the backroom outstanding shares, and other issues, but when I see a company with such a product potential this far along that also has experience at and revenue from actual product production and delivery in related areas; I would really think the value of this company should be at least 500 million today. If I assume a future diluted total outstanding share value 50 million shares; that is at least $10/share. But that is today, after PD program and TBI, it should multiples of that. A cap of only 50 million with the listed O/S is over $12/share.

Bottom line, regardless of your take or investment direction in ISCO, IMHO, I think you should want this to work out well for the sake of peoples lives.